( NASDAQ-SMALL:BLRX,TelAviv:BLRX )

News from BioLineRx A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 16, 2016, 07:00 ET BioLineRx and MaRS Innovation Sign Framework Collaboration Agreement

BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising...


May 10, 2016, 08:00 ET BioLineRx to Report First Quarter 2016 Results on May 17, 2016

BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising...


Apr 04, 2016, 07:00 ET BioLineRx's Novel Treatment for Non-Surgical Removal of Skin Lesions Receives CE Mark Approval

BioLineRx Ltd. (NASDAQ/TASE: BLRX) announced today that its partner, Omega Pharma, now part of Perrigo, has received CE Mark approval for BL-5010...


Mar 29, 2016, 07:00 ET BioLineRx Reports Successful Top-Line Results in Phase 2 Trial for AML

BioLineRx (NASDAQ/TASE: BLRX) announced today positive top-line results from BL-8040's Phase 2 clinical trial in relapsed or refractory acute...


Mar 10, 2016, 06:00 ET BioLineRx to Present at 2016 Annual Roth Conference in Southern California on March 14

BioLineRx (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising...